Enzychem Lifesciences Corporation
Enzychem Lifesciences Corporation operates in Diversified Metals & Mining.
Market Cap & Net Worth: Enzychem Lifesciences Corporation (183490)
Enzychem Lifesciences Corporation (KO:183490) has a market capitalization of $7.44K (₩10.89 Million) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #45445 globally and #2616 in its home market, demonstrating a 12.74% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Enzychem Lifesciences Corporation's stock price ₩1115.00 by its total outstanding shares 9766 (9.77K).
Enzychem Lifesciences Corporation Market Cap History: 2016 to 2026
Enzychem Lifesciences Corporation's market capitalization history from 2016 to 2026. Data shows change from $35.54K to $7.44K (-18.52% CAGR).
Enzychem Lifesciences Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Enzychem Lifesciences Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Enzychem Lifesciences Corporation's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $35.54K | $21.84 Billion | -$6.33 Billion | 0.00x | N/A |
| 2017 | $46.83K | $26.13 Billion | -$5.67 Billion | 0.00x | N/A |
| 2018 | $86.90K | $31.03 Billion | -$14.42 Billion | 0.00x | N/A |
| 2019 | $61.86K | $31.47 Billion | -$16.88 Billion | 0.00x | N/A |
| 2020 | $92.61K | $25.82 Billion | -$17.51 Billion | 0.00x | N/A |
| 2021 | $61.03K | $22.98 Billion | -$27.86 Billion | 0.00x | N/A |
| 2022 | $11.04K | $26.64 Billion | -$25.09 Billion | 0.00x | N/A |
| 2023 | $12.13K | $76.04 Billion | -$9.33 Billion | 0.00x | N/A |
Competitor Companies of 183490 by Market Capitalization
Companies near Enzychem Lifesciences Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to Enzychem Lifesciences Corporation by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
Enzychem Lifesciences Corporation Historical Marketcap From 2016 to 2026
Between 2016 and today, Enzychem Lifesciences Corporation's market cap moved from $35.54K to $ 7.44K, with a yearly change of -18.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩7.44K | -27.12% |
| 2025 | ₩10.20K | +7.37% |
| 2024 | ₩9.50K | -21.62% |
| 2023 | ₩12.13K | +9.85% |
| 2022 | ₩11.04K | -81.91% |
| 2021 | ₩61.03K | -34.10% |
| 2020 | ₩92.61K | +49.72% |
| 2019 | ₩61.86K | -28.82% |
| 2018 | ₩86.90K | +85.55% |
| 2017 | ₩46.83K | +31.77% |
| 2016 | ₩35.54K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Enzychem Lifesciences Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.44K USD |
| MoneyControl | $7.44K USD |
| MarketWatch | $7.44K USD |
| marketcap.company | $7.44K USD |
| Reuters | $7.44K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.